Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2021 / N 2

Терапевтический лекарственный мониторинг ванкомицина у новорожденных: проблемы и перспективы
Б.Е. Толкачев, В.И. Петров, Т.Е. Заячникова, А.В. Стрыгин, И.С. Аникеев, А.М. Доценко

Список литературы

1. Tzialla C, Borghesi A, Serra G, Stronati M, Corsello G. Antimicrobial therapy in neonatal intensive care unit. Italian Journal of Pediatrics 2015 Apr;41(1):1-6.
2. Bhongsatiern J, Stockmann C, Roberts JK, Yu T, Korgenski KE, Spigarelli MG, Desai PB, Sherwin C. Evaluation of vancomycin use in late-onset neonatal sepsis using the area under the concentration-time curve to the minimum inhibitory concentration ≥400 target. Therapeutic Drug Monitoring 2015 Dec;37(6):756-65.
3. Reilly AM, Ding MX, Rower JE, Kiser TH. The effectiveness of a vancomycin dosing guideline in the neonatal intensive care unit for achieving goal therapeutic trough concentrations. Journal of Clinical Pharmacology 2019 Jul;59(7):997-1005.
4. Pauwels S, Allegaert K. Therapeutic drug monitoring in neonates. Archives of Disease in Childhood 2016 Apr;101(4):377-81.
5. Mian P, Flint RB, Tibboel D, van den Anker JN, Allegaert K, Koch BCP. Therapeutic drug monitoring in neonates: what makes them unique? Current Pharmaceutical Design 2017;23(38):5790-800.
6. Janssen EJ, Välitalo PA, Allegaert K, de Cock RF, Simons SH, Sherwin CM, Mouton JW, van den Anker JN, Knibbe CA. Towards rational dosing algorithms for vancomycin in neonates and infants based on population pharmacokinetic modeling. Antimicrobial Agents and Chemotherapy 2016 Feb;60(2):1013-21.
7. Madigan T, Teng CB, Koshaish J, Johnson KR, Graner KK, Banerjee R. Optimization of vancomycin dosing in very low-birth-weight preterm neonates. American Journal of Perinatology 2015 Jan;32(1):83-6.
8. Kim J, Walker SA, Iaboni DC, Walker SE, Elligsen M, Dunn MS, Allen VG, Simor A. Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations. Antimicrobial Agents and Chemotherapy 2014 May;58(5):2830-40.
9. Kato H, Hagihara M, Nishiyama N, Koizumi Y, Mikamo H, Matsuura K, Yamagishi Y. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates. Journal of Infection and Chemotherapy 2017 Mar;23(3):154-60.
10. Anderson BJ, Allegaert K, Van den Anker JN, Cossey V, Holford NHG. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. British Journal of Clinical Pharmacology 2007 Jan;63(1):75-84.
11. Allegaert K. The impact of ibuprofen or indomethacin on renal drug clearance in neonates. The Journal of Maternal-Fetal & Neonatal Medicine 2009;22(Suppl 3):88-91.
12. Chen Y, Wu D, Dong M, Zhu Y, Lu J, Li X, Chen C, Li Z. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants. European Journal of Clinical Pharmacology 2018 Jul;74(7):921-30.
13. Ringenberg T, Robinson C, Meyers R, Degnan L, Shah P, Siu A, Sturgill M. Achievement of therapeutic vancomycin trough serum concentrations with empiric dosing in neonatal intensive care unit patients. The Pediatric Infectious Disease Journal 2015 Jul;34(7):742-7.
14. Tseng S-H, Lim CP, Chen Q, Tang CC, Kong ST, Ho PC. Evaluating the relationship between vancomycin trough concentration and 24-hour area under the concentration–time curve in neonates. Antimicrobial Agents and Chemotherapy. 2018 Mar 27;62(4):e01647-17.
15. Jacqz-Aigrain E, Leroux S, Thomson AH, Allegaert K, Capparelli EV, Biran V, Simon N, Meibohm B, Lo YL, Marques R, Peris JE, Lutsar I, Saito J, Nakamura H, van den Anker JN, Sharland M, Zhao W. Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants. The Journal of Antimicrobial Chemotherapy. 2019 Aug 1;74(8):2128-38.
16. Allegaert K, Flint R, Smits A. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle. Expert Opinion on Drug Metabolism & Toxicology 2019 Sep;15(9):735-49.
17. Wilhelm AJ, den Burger JCG, Swart EL. Therapeutic drug monitoring by dried blood spot: progress to date and future directions. Clinical Pharmacokinetics 2014 Nov;53(11):961-73.
18. Wagner M, Tonoli D, Varesio E, Hopfgartner G. The use of mass spectrometry to analyze dried blood spots. Mass Spectrometry Reviews 2016 May-Jun;35(3):361-438.
19. Tasa T, Metsvaht T, Kalamees R, Vilo J, Lutsar I. DosOpt: a tool for personalized Bayesian dose adjustment of vancomycin in neonates. Therapeutic Drug Monitoring 2017 Dec;39(6):604-13.

References

1. Tzialla C, Borghesi A, Serra G, Stronati M, Corsello G. Antimicrobial therapy in neonatal intensive care unit. Italian Journal of Pediatrics 2015 Apr;41(1):1-6.
2. Bhongsatiern J, Stockmann C, Roberts JK, Yu T, Korgenski KE, Spigarelli MG, Desai PB, Sherwin C. Evaluation of vancomycin use in late-onset neonatal sepsis using the area under the concentration-time curve to the minimum inhibitory concentration ≥400 target. Therapeutic Drug Monitoring 2015 Dec;37(6):756-65.
3. Reilly AM, Ding MX, Rower JE, Kiser TH. The effectiveness of a vancomycin dosing guideline in the neonatal intensive care unit for achieving goal therapeutic trough concentrations. Journal of Clinical Pharmacology 2019 Jul;59(7):997-1005.
4. Pauwels S, Allegaert K. Therapeutic drug monitoring in neonates. Archives of Disease in Childhood 2016 Apr;101(4):377-81.
5. Mian P, Flint RB, Tibboel D, van den Anker JN, Allegaert K, Koch BCP. Therapeutic drug monitoring in neonates: what makes them unique? Current Pharmaceutical Design 2017;23(38):5790-800.
6. Janssen EJ, Välitalo PA, Allegaert K, de Cock RF, Simons SH, Sherwin CM, Mouton JW, van den Anker JN, Knibbe CA. Towards rational dosing algorithms for vancomycin in neonates and infants based on population pharmacokinetic modeling. Antimicrobial Agents and Chemotherapy 2016 Feb;60(2):1013-21.
7. Madigan T, Teng CB, Koshaish J, Johnson KR, Graner KK, Banerjee R. Optimization of vancomycin dosing in very low-birth-weight preterm neonates. American Journal of Perinatology 2015 Jan;32(1):83-6.
8. Kim J, Walker SA, Iaboni DC, Walker SE, Elligsen M, Dunn MS, Allen VG, Simor A. Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations. Antimicrobial Agents and Chemotherapy 2014 May;58(5):2830-40.
9. Kato H, Hagihara M, Nishiyama N, Koizumi Y, Mikamo H, Matsuura K, Yamagishi Y. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates. Journal of Infection and Chemotherapy 2017 Mar;23(3):154-60.
10. Anderson BJ, Allegaert K, Van den Anker JN, Cossey V, Holford NHG. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. British Journal of Clinical Pharmacology 2007 Jan;63(1):75-84.
11. Allegaert K. The impact of ibuprofen or indomethacin on renal drug clearance in neonates. The Journal of Maternal-Fetal & Neonatal Medicine 2009;22(Suppl 3):88-91.
12. Chen Y, Wu D, Dong M, Zhu Y, Lu J, Li X, Chen C, Li Z. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants. European Journal of Clinical Pharmacology 2018 Jul;74(7):921-30.
13. Ringenberg T, Robinson C, Meyers R, Degnan L, Shah P, Siu A, Sturgill M. Achievement of therapeutic vancomycin trough serum concentrations with empiric dosing in neonatal intensive care unit patients. The Pediatric Infectious Disease Journal 2015 Jul;34(7):742-7.
14. Tseng S-H, Lim CP, Chen Q, Tang CC, Kong ST, Ho PC. Evaluating the relationship between vancomycin trough concentration and 24-hour area under the concentration–time curve in neonates. Antimicrobial Agents and Chemotherapy. 2018 Mar 27;62(4):e01647-17.
15. Jacqz-Aigrain E, Leroux S, Thomson AH, Allegaert K, Capparelli EV, Biran V, Simon N, Meibohm B, Lo YL, Marques R, Peris JE, Lutsar I, Saito J, Nakamura H, van den Anker JN, Sharland M, Zhao W. Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants. The Journal of Antimicrobial Chemotherapy. 2019 Aug 1;74(8):2128-38.
16. Allegaert K, Flint R, Smits A. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle. Expert Opinion on Drug Metabolism & Toxicology 2019 Sep;15(9):735-49.
17. Wilhelm AJ, den Burger JCG, Swart EL. Therapeutic drug monitoring by dried blood spot: progress to date and future directions. Clinical Pharmacokinetics 2014 Nov;53(11):961-73.
18. Wagner M, Tonoli D, Varesio E, Hopfgartner G. The use of mass spectrometry to analyze dried blood spots. Mass Spectrometry Reviews 2016 May-Jun;35(3):361-438.
19. Tasa T, Metsvaht T, Kalamees R, Vilo J, Lutsar I. DosOpt: a tool for personalized Bayesian dose adjustment of vancomycin in neonates. Therapeutic Drug Monitoring 2017 Dec;39(6):604-13.
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]